Workshop hosted by the Centre for Cellular And Molecular Platforms (C-CAMP), a member of the CARB-X Accelerator Network.

Speakers include Kevin Outterson, CARB-X Executive Director. The Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.  

Global views, local problems: Innovative solutions to AMR and infection challenges. The British Society for Antimicrobial Chemotherapy (BSAC) 2019 Spring Conference offers a state of the art overview of the infection management and antimicrobial resistance landscape. The programme includes keynote lectures, plenary and parallel sessions, debates and an opening series of spotlight presentations – offering insights into the latest in drug discovery and development, socio-economic challenges, new and emerging treatments and diagnostics and debates and challenges policies and usage of…

Speakers include Kevin Outterson, CARB-X Executive Director. The Longitude Prize is an international challenge prize competition that will ultimately select one point-of-care diagnostic product to receive a grand payout of 8 million British Pounds ($9.1 million). The winner will have proven that their test can significantly reduce misuse or overuse of antibiotics by creating an affordable, accurate and rapid point-of-care diagnostic test. This test must be practical to use in the North America and Europe as well as low and…

Speakers include Karen Gallant, CARB-X Global Project Director. The 1st Bacteriophage Therapy Summit is the only meeting uniting large pharma, biotech companies, research institutions and technology experts to harness bacteriophage science and accelerate the clinical development of effective phage therapy. Join the leaders in phage therapy product development as they discuss the latest data-driven case studies and forge collaborations you need to unlock the full potential of bacteriophage therapeutics. See the full agenda and speaker list here. CARB-X subscribers qualify…

Speakers include Kevin Outterson, CARB-X Executive Director. Join 120+ health policy leaders, academics and other experts across the industry for a frank discussion to catalyse progress in bringing AMR under control, before it is too late. A series of expert panel discussions will dig into the topics that matter the most, using the convening power of The Economist brand to get the right people working together.

The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this third webinar, we will discuss the development of antibacterial drug enhancer combinations and non-traditional products. The presentations will be followed by a Q&A session.

ECCMID, as the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts from many fields to present their latest findings, guidelines and experiences to an audience of over 12,000 colleagues. This year, the Programme Committee has developed a multi-faceted program incorporating keynote lectures and oral sessions, as well as interactive workshops, meet-the-expert sessions, and a wide range of symposia.